H4 ORPHAN PHARMA has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are NEUTEC AR GE SANAYI VE TICARET ANONIM SIRKETI, IX BIOPHARMA LTD and OCULAR TECH SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | France | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Bur Catherine | 10 |
#2 | Terrasse Gaëtan | 7 |
#3 | Terrasse Gaetan | 3 |
#4 | Gaëtan Terrasse | 1 |
#5 | Catherine Bur | 1 |
Publication | Filing date | Title |
---|---|---|
FR3096890A1 | Use of an opioid molecule to treat dry eye and allergic eye. |